MedPath

Cognitive Behaviour Therapy for Sleep Problems in Children With Autism Spectrum Disorder

Not Applicable
Conditions
Cognitive Behaviour Therapy
Autism Spectrum Disorder
Interventions
Behavioral: Cognitive behaviour therapy for insomnia
Behavioral: psychoeducation for ASD
Registration Number
NCT04319640
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Brief Summary

Sleep disturbance is very common in children with autism spectrum disorder (ASD),and closely associated with their core symptom, social deficit.This trial investigates the effects of Cognitive behaviour therapy for insomnia (CBT-I) in children with autism spectrum disorder with sleep problems through synchronized eye-tracking and functional near-infrared spectroscopy (fNIRS). This is a 1:1 parallel single-blind randomized controlled trial.

Detailed Description

sleep disturbance is significantly associated with social deficit of ASD and but the congnitive-neural mechanism underlying this association remains unclear. Cognitive behaviour therapy for insomnia (iCBT-I) is considered as an evidence-based treatment for insomnia. After 5 consecutive sleep interventions is a 2-year following up study, the above issue is further tested with emphasis on progressive trajectory from a developmental perspective. we examine the influence of sleep disturbance on face processing and neural response during naturalistic social behavior of ASD children using synchronized eye-tracking and functional near-infrared spectroscopy (fNIRS) to uncover the neural mechanism for that sleep disturbance influences social deficit.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  1. meet the diagnostic criteria for autism DSM-5 and ADOS-2;
  2. age 24months to 59months s old;
  3. willing to participate in this study, and can complete the following assessments at the specific time.
Exclusion Criteria

Exclusion of severe respiratory diseases, schizophrenia, epilepsy and other brain diseases;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CBTICognitive behaviour therapy for insomniaN= 80 participants are offered Cognitive behaviour therapy for insomnia (CBT-I)
psychoeducationpsychoeducation for ASDN= 80 participants are offered psychoeducation about information on ASD
CBTIpsychoeducation for ASDN= 80 participants are offered Cognitive behaviour therapy for insomnia (CBT-I)
Primary Outcome Measures
NameTimeMethod
congnitive-neural outcomeschanges from baseline, 6 months after the intervention, 12 months after the intervention and 6 year olds

The investigators examine the influence of sleep disorders on face processing and neural response at baseline, 6 months after the intervention, 12 months after the intervention and when children 6 year olds by synchronized eye-tracking and functional near-infrared spectroscopy (fNIRS) to uncover the neural mechanism for that sleep disturbance influences social-emotional development.

ADOS-2changes from baseline, 6 months after the intervention, 12 months after the intervention and 6 year olds

The ADOS-2 is the standard instrument for assessing autism spectrum disorders (ASD) across age, developmental level, and language skills.

Secondary Outcome Measures
NameTimeMethod
Sleep diaries by using Actigraphychanges from baseline, 6 months after the intervention, 12 months after the intervention and 6 year olds

Different sleep parameters, such as sleep onset latency (SOL) and wake after sleep onset (WASO) will be determined using wrist actigraphy. Participants will be provided with an actiwatch at baseline, 6 months after the intervention , 12 months after the intervention and when children 6 year olds . The actiwatch will be worn on the non-dominant arm 24 hours a day, except for while bathing, during the 1-week screening periodmovement and nighttime sleep parameters.

Trial Locations

Locations (1)

shanghai children's medicial center affiliated shanghai jiaotong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath